Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,796 | 31,770 | 69,275 | 37,462 | N/A |
| Marketable Securities | 256,605 | 58,599 | 50,710 | 106,034 | N/A |
| Receivables | 82,054 | 185,854 | 43,306 | 51,503 | N/A |
| Inventories | 44,549 | 49,130 | 32,305 | 27,568 | N/A |
| Income taxes - deferred | 39,271 | 32,286 | 17,900 | 27,376 | N/A |
| Other current assets | 2,012 | 11,624 | 13,578 | 11,923 | 0 |
| TOTAL | $520,694 | $374,011 | $236,372 | $270,458 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 106,280 | 101,650 | 95,629 | 81,223 | N/A |
| Intangibles | 27,574 | 27,574 | 27,574 | 27,574 | 0 |
| Other Non-Current Assets | 38,770 | 157,521 | 154,712 | 137,204 | 0 |
| TOTAL | $172,624 | $286,745 | $277,915 | $246,001 | $N/A |
| Total Assets | $693,318 | $660,756 | $514,287 | $516,459 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 14,416 | 69,234 | N/A |
| Accounts payable and accrued liabilities | 18,812 | 23,295 | 12,797 | 16,898 | 0 |
| Accrued Expenses | 89,328 | 147,377 | 41,360 | 35,838 | N/A |
| TOTAL | $126,416 | $203,868 | $109,588 | $160,351 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 5,990 | 7,760 | N/A |
| Deferred Revenues | 18,276 | 33,196 | 35,015 | 26,381 | N/A |
| Other Non-Current Liabilities | 14,558 | 10,229 | 13,302 | 32,523 | 0 |
| TOTAL | $58,753 | $234,661 | $245,049 | $221,941 | $N/A |
| Total Liabilities | $185,169 | $438,529 | $354,637 | $382,292 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,819 | 62,022 | N/A | N/A | N/A |
| Common Shares | 647 | 622 | 602 | 591 | N/A |
| Retained earnings | 251,246 | 828 | -49,233 | -60,290 | N/A |
| Other shareholders' equity | 2,816 | -462 | -847 | -183 | 0 |
| TOTAL | $508,149 | $222,227 | $159,650 | $134,167 | $N/A |
| Total Liabilities And Equity | $693,318 | $660,756 | $514,287 | $516,459 | $0 |